封面
市場調查報告書
商品編碼
1565708

分子靶向診斷市場,按產品、按應用、按技術、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Molecular Targeted Diagnostics Market, By Product, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年分子標靶診斷市場規模為154.0833億美元,2024年至2032年複合年成長率為7.02%。

分子標靶診斷市場-市場動態

癌症盛行率的增加以及早期和準確檢測的需求,篩檢預計將推動市場需求

全球癌症發生率不斷上升,導致對能夠及早準確檢測癌症的診斷方法的需求不斷增加。分子診斷為驅動腫瘤生長的基因改變提供了寶貴的見解,從而透過標靶治療獲得更好的結果。人們對遺傳性疾病和罕見疾病的認知不斷增強,以及對早期準確檢測的需求,增加了對分子標靶診斷的需求,從而促進了市場成長。這些測試有助於識別遺傳性疾病並協助產前篩檢和新生兒檢測。

人們對早期診斷和篩檢預防疾病進展的認知不斷提高,推動了對分子標靶診斷的需求。公共衛生措施正在推動癌症、遺傳性疾病和傳染病篩檢計畫的採用。由於個人化醫療的進步、癌症和遺傳疾病盛行率的增加、技術創新以及液體活體組織切片等非侵入性診斷技術的廣泛使用,分子標靶診斷市場正在經歷顯著成長。

分子標靶診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 7.02% 左右的複合年成長率成長

根據產品細分,由於診所和研究行業的高度採用,預計試劑細分市場將在 2023 年顯示最大的市場佔有率。

根據應用細分,由於傳染病和病毒性疾病的盛行率不斷上升,傳染病領域是 2023 年領先的應用領域。

從技術細分來看,由於對治療傳染病的高需求,聚合酶鏈反應(PCR)領域將成為 2023 年領先的技術領域。

從地區來看,由於政府在新藥開發方面的支持舉措,北美將成為 2023 年的主要收入來源。

分子標靶診斷市場-細分分析:

全球分子標靶診斷市場根據產品、應用、技術和地區進行細分。

市場依產品分為三類:儀器、試劑和其他。試劑細分市場佔據主導地位。新穎測試的日益採用和研究活動的不斷增加正在促進市場成長。

市場依應用分為六類:傳染病、藥物基因體學、腫瘤學、基因檢測、微生物學等。傳染病細分市場佔據主導地位。分子診斷對於傳染病治療是有效且至關重要的,這是增加市場成長的主要因素。

根據技術,市場分為五大類:PCR、晶片和微陣列、質譜、定序等。 PCR 領域在市場上佔據主導地位,預計在預測期內將保持其高度主導地位。 COVID-19 和其他傳染病的不斷出現推動了對分子診斷需求的需求。

分子標靶診斷市場-地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。在醫療保健投資增加、癌症發病率上升以及先進診斷技術更廣泛採用的推動下,亞太地區正在經歷顯著成長。中國是該地區的主要驅動力,擁有快速成長的精準醫療市場、政府對基因研究的支持以及癌症盛行率的上升。歐洲是分子標靶診斷市場的另一個重要參與者,以德國、英國和法國等國家為首。美國在創新方面處於領先地位,擁有大量臨床試驗和伴隨診斷的批准。

分子標靶診斷市場-競爭格局:

分子標靶診斷市場競爭激烈,擁有許多成熟企業和創新新創公司。技術進步、合作關係以及對精準醫療不斷成長的需求推動了競爭。公司專注於獲得伴隨診斷的監管批准,特別是在美國和歐洲。擴展到亞太和拉丁美洲等新興市場也是許多公司的關鍵成長策略。多家公司正在與製藥公司建立合作關係,共同開發伴隨診斷技術。這種趨勢在腫瘤學領域尤其強烈,羅氏、凱杰和賽默飛世爾等公司正在引領癌症標靶治療診斷技術的開發。

2024 年 7 月,賽默飛世爾科技完成了對 Olink Holdings AB 的收購,以擴大其在歐洲的業務範圍。

2022 年,Illumina Inc. 開發了多種針對癌症的面板,包括用於全面基因組分析的 TruSight Oncology 500。

2021 年,羅氏收購了 GenMark Diagnostics,擴大了其在多重分子診斷領域的產品組合。

目錄

第 1 章:分子標靶診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 分子標靶診斷市場片段(按產品)
    • 按應用分列的分子標靶診斷市場片段
    • 分子標靶診斷市場技術片段
    • 按國家/地區分類的分子標靶診斷市場片段
    • 按地區分類的分子標靶診斷市場片段
  • 競爭洞察

第 3 章:分子標靶診斷主要市場趨勢

  • 分子標靶診斷市場促進因素
    • 市場促進因素的影響分析
  • 分子標靶診斷市場限制
    • 市場限制影響分析
  • 分子標靶診斷市場機會
  • 分子標靶診斷市場未來趨勢

第 4 章:分子標靶診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:分子標靶診斷市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:分子標靶診斷市場格局

  • 2023 年分子標靶診斷市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:分子標靶診斷市場 - 按產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 儀器儀表
    • 試劑
    • 其他

第 8 章:分子標靶診斷市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 傳染病
    • 藥物基因組學
    • 腫瘤學
    • 基因檢測
    • 微生物學
    • 其他

第 9 章:分子標靶診斷市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 聚合酶鍊式反應
    • 晶片和微陣列
    • 質譜分析
    • 定序
    • 其他

第 10 章:分子標靶診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美分子靶向診斷主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按產品)
    • 北美市場規模和預測(按應用)
    • 北美市場規模和預測(按技術)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲分子靶向診斷主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按產品)
    • 歐洲市場規模和預測(按應用)
    • 歐洲市場規模與預測(按技術)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區分子標靶診斷主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按產品)
    • 亞太地區市場規模與預測(按應用)
    • 亞太地區市場規模與預測(按技術)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲分子靶向診斷主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按產品)
    • 拉丁美洲市場規模與預測(按應用)
    • 拉丁美洲市場規模與預測(按技術)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲分子靶向診斷主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按產品)
    • 中東和非洲市場規模及預測(按應用)
    • 中東和非洲市場規模及預測(按技術)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章:主要供應商分析 - 分子標靶診斷產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Qiagen NV
    • Abbott Laboratories
    • Illumina, Inc.
    • Agilent Technologies
    • Bio-Rad Laboratories
    • Becton, Dickinson and Company (BD)
    • Hologic, Inc.
    • Myriad Genetics, Inc.
    • Siemens Healthineers
    • Danaher Corporation
    • Genomic Health
    • Sysmex Corporation
    • Grifols SA
    • bioMerieux SA
    • Others

第 12 章:360 度分析師視角

第 13 章:附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3905

REPORT HIGHLIGHT

Molecular Targeted Diagnostics Market size was valued at USD 15,408.33 Million in 2023, expanding at a CAGR of 7.02% from 2024 to 2032.

Molecular targeted diagnostics focuses on identifying specific molecular markers in a patient's body usually in cells, tissues, or bodily fluids. These molecular markers often include DNA, RNA, proteins, and other biomolecules. The primary purpose is to detect abnormalities at the molecular level that may be indicative of diseases such as cancer, cardiovascular disorders, or genetic conditions.

Molecular Targeted Diagnostics Market- Market Dynamics

Increasing prevalence of cancer and the need for early & accurate detection, screening is expected to propel market demand

The rising global incidence of cancer has led to an increased need for diagnostic methods that can detect cancers early and accurately. Molecular diagnostics provide valuable insights into the genetic alterations that drive tumor growth, leading to better outcomes with targeted therapies. The growing awareness of genetic disorders and rare diseases, as well as the need for early and accurate detection, is increasing the demand for molecular targeted diagnostics, thereby boosting market growth. These tests help in identifying hereditary conditions and assist in prenatal screening and newborn testing.

Growing awareness of early diagnosis and screening in preventing disease progression is driving the demand for molecular targeted diagnostics. Public health initiatives are promoting the adoption of screening programs for cancer, genetic disorders, and infectious diseases. The molecular targeted diagnostics market is experiencing significant growth due to advancements in personalized medicine, the increasing prevalence of cancer and genetic diseases, technological innovations, and the expanding use of non-invasive diagnostic techniques like liquid biopsy.

Molecular Targeted Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.02% over the forecast period (2024-2032)

Based on Product segmentation, the reagents segment was predicted to show maximum market share in the year 2023, owing to high adoption in clinics & research industry.

Based on Application segmentation, infectious diseases segment was the leading Application segment in 2023, due to the growing prevalence of infectious & viral disorders.

Based on Technology segmentation, polymerase chain reaction (PCR) segment was the leading Technology segment in 2023, due to high demand for treating infectious diseases.

On the basis of region, North America was the leading revenue generator in 2023, due to the supportive government initiatives in new drugs development.

Molecular Targeted Diagnostics Market- Segmentation Analysis:

The Global Molecular Targeted Diagnostics Market is segmented on the basis of Product, Application, Technology, and Region.

The market is divided into three categories based on Product: instruments, reagents, and others. The reagents segment dominates the market. The increasing adoption of novel tests and growing research activities is fostering market growth.

The market is divided into six categories based on Application: infectious diseases, pharmacogenomics, oncology, genetic testing, microbiology, and others. The infectious diseases segment dominates the market. The molecular diagnosis is effective & vital in infectious disorders cure which is the main factor increasing market growth.

The market is divided into five categories based on Technology: PCR, chips & microarrays, mass spectrometry, sequencing, and others. The PCR segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing emergence during COVID-19 and other infectious diseases have fueled the demand for molecular diagnostics demand.

Molecular Targeted Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is witnessing significant growth, driven by increasing healthcare investments, rising cancer incidences, and greater adoption of advanced diagnostics. China is a major driver in the region, with a rapidly growing precision medicine market, government support for genetic research, and an increasing prevalence of cancer. Europe is another significant player in the molecular targeted diagnostics market, led by countries like Germany, the U.K., and France. The U.S. leads in innovation, with numerous clinical trials and approvals of companion diagnostics.

Molecular Targeted Diagnostics Market- Competitive Landscape:

The Molecular Targeted Diagnostics market is highly competitive and features numerous established players and innovative startups. The competition is driven by advancements in technology, partnerships, and the rising demand for precision medicines. Companies are focused on obtaining regulatory approvals for companion diagnostics, particularly in the U.S. and Europe. Expanding into emerging markets, such as Asia-Pacific and Latin America, is also a key growth strategy for many firms. Several companies are forming partnerships with pharmaceutical firms to co-develop companion diagnostics. This trend is particularly strong in oncology, where companies like Roche, Qiagen, and Thermo Fisher are leading the development of diagnostics for targeted cancer therapies.

In July 2024, Thermo Fisher Scientific completed the acquisition of Olink Holdings AB to expand their reach across Europe.

In 2022, Illumina Inc., has developed several cancer-focused panels, including the TruSight Oncology 500, which is used for comprehensive genomic profiling.

In 2021, Roche acquired GenMark Diagnostics, expanding its portfolio in multiplex molecular diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Qiagen N.V.
  • Abbott Laboratories
  • Illumina, Inc.
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Becton, Dickinson and Company (BD)
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • Genomic Health
  • Sysmex Corporation
  • Grifols SA
  • bioMerieux SA
  • Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Instruments
  • Reagents
  • Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Infectious diseases
  • Pharmacogenomics
  • Oncology
  • Genetic testing
  • Microbiology
  • Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

  • PCR
  • Chips & microarrays
  • Mass spectrometry
  • Sequencing
  • Others

GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Targeted Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Targeted Diagnostics Market Snippet by Product
    • 2.1.2. Molecular Targeted Diagnostics Market Snippet by Application
    • 2.1.3. Molecular Targeted Diagnostics Market Snippet by Technology
    • 2.1.4. Molecular Targeted Diagnostics Market Snippet by Country
    • 2.1.5. Molecular Targeted Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Targeted Diagnostics Key Market Trends

  • 3.1. Molecular Targeted Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Targeted Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Targeted Diagnostics Market Opportunities
  • 3.4. Molecular Targeted Diagnostics Market Future Trends

4. Molecular Targeted Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Targeted Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Molecular Targeted Diagnostics Market Landscape

  • 6.1. Molecular Targeted Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Targeted Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents
    • 7.1.4. Others

8. Molecular Targeted Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Infectious diseases
    • 8.1.3. Pharmacogenomics
    • 8.1.4. Oncology
    • 8.1.5. Genetic testing
    • 8.1.6. Microbiology
    • 8.1.7. Others

9. Molecular Targeted Diagnostics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. PCR
    • 9.1.3. Chips & microarrays
    • 9.1.4. Mass spectrometry
    • 9.1.5. Sequencing
    • 9.1.6. Others

10. Molecular Targeted Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Molecular Targeted Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Molecular Targeted Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Molecular Targeted Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Molecular Targeted Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Molecular Targeted Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Molecular Targeted Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Qiagen N.V.
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Illumina, Inc.
    • 11.2.5. Agilent Technologies
    • 11.2.6. Bio-Rad Laboratories
    • 11.2.7. Becton, Dickinson and Company (BD)
    • 11.2.8. Hologic, Inc.
    • 11.2.9. Myriad Genetics, Inc.
    • 11.2.10. Siemens Healthineers
    • 11.2.11. Danaher Corporation
    • 11.2.12. Genomic Health
    • 11.2.13. Sysmex Corporation
    • 11.2.14. Grifols SA
    • 11.2.15. bioMerieux SA
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us